Skip to content

TriSalus Life Sciences, Inc. TLSI Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Rumble, Inc. logo
Rumble, Inc.RUM
-$337.78K-40.4%
SelectQuote logo
SelectQuoteSLQT
-$1.12M+13.3%
Mission Produce, Inc. logo
Mission Produce, Inc.AVO
-$2.8M-3.7%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4.74M-16.2%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
-$1.68M-6.3%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities?
TriSalus Life Sciences, Inc. (TLSI) reported short- and long-term operating lease liabilities of -$31K in Q1 2026.
How has TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities increased by 44.6% year-over-year, from -$56K to -$31K.
What is the long-term trend for TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities?
Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s short- and long-term operating lease liabilities has grown at a -30.9% compound annual growth rate (CAGR), from -$281K to -$134K.